117 related articles for article (PubMed ID: 35367635)
1. Extracolonic tumours in a pedigree with EPCAM-related Lynch Syndrome.
Alves da Silva J; Castedo S; Pedroto I; Marcos-Pinto R
Eur J Med Genet; 2022 May; 65(5):104479. PubMed ID: 35367635
[TBL] [Abstract][Full Text] [Related]
2. Lynch syndrome-associated extracolonic tumors are rare in two extended families with the same EPCAM deletion.
Lynch HT; Riegert-Johnson DL; Snyder C; Lynch JF; Hagenkord J; Boland CR; Rhees J; Thibodeau SN; Boardman LA; Davies J; Kuiper RP; Hoogerbrugge N; Ligtenberg MJ
Am J Gastroenterol; 2011 Oct; 106(10):1829-36. PubMed ID: 21769135
[TBL] [Abstract][Full Text] [Related]
3. Frequency of rearrangements in Lynch syndrome cases associated with MSH2: characterization of a new deletion involving both EPCAM and the 5' part of MSH2.
Pérez-Cabornero L; Infante Sanz M; Velasco Sampedro E; Lastra Aras E; Acedo Becares A; Miner Pino C; Durán Domínguez M
Cancer Prev Res (Phila); 2011 Oct; 4(10):1556-62. PubMed ID: 21791569
[TBL] [Abstract][Full Text] [Related]
4. Identification of a Japanese Lynch syndrome patient with large deletion in the 3' region of the EPCAM gene.
Eguchi H; Kumamoto K; Suzuki O; Kohda M; Tada Y; Okazaki Y; Ishida H
Jpn J Clin Oncol; 2016 Feb; 46(2):178-84. PubMed ID: 26613680
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of epithelial cell adhesion molecule expression in the algorithmic approach to Lynch syndrome identification.
Musulen E; Blanco I; Carrato C; Fernandez-Figueras MT; Pineda M; Capella G; Ariza A
Hum Pathol; 2013 Mar; 44(3):412-6. PubMed ID: 23026194
[TBL] [Abstract][Full Text] [Related]
6. The molecular basis of EPCAM expression loss in Lynch syndrome-associated tumors.
Huth C; Kloor M; Voigt AY; Bozukova G; Evers C; Gaspar H; Tariverdian M; Schirmacher P; von Knebel Doeberitz M; Bläker H
Mod Pathol; 2012 Jun; 25(6):911-6. PubMed ID: 22388758
[TBL] [Abstract][Full Text] [Related]
7. EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients.
Ligtenberg MJ; Kuiper RP; Geurts van Kessel A; Hoogerbrugge N
Fam Cancer; 2013 Jun; 12(2):169-74. PubMed ID: 23264089
[TBL] [Abstract][Full Text] [Related]
8. Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study.
Kempers MJ; Kuiper RP; Ockeloen CW; Chappuis PO; Hutter P; Rahner N; Schackert HK; Steinke V; Holinski-Feder E; Morak M; Kloor M; Büttner R; Verwiel ET; van Krieken JH; Nagtegaal ID; Goossens M; van der Post RS; Niessen RC; Sijmons RH; Kluijt I; Hogervorst FB; Leter EM; Gille JJ; Aalfs CM; Redeker EJ; Hes FJ; Tops CM; van Nesselrooij BP; van Gijn ME; Gómez García EB; Eccles DM; Bunyan DJ; Syngal S; Stoffel EM; Culver JO; Palomares MR; Graham T; Velsher L; Papp J; Oláh E; Chan TL; Leung SY; van Kessel AG; Kiemeney LA; Hoogerbrugge N; Ligtenberg MJ
Lancet Oncol; 2011 Jan; 12(1):49-55. PubMed ID: 21145788
[TBL] [Abstract][Full Text] [Related]
9. Recurrence and variability of germline EPCAM deletions in Lynch syndrome.
Kuiper RP; Vissers LE; Venkatachalam R; Bodmer D; Hoenselaar E; Goossens M; Haufe A; Kamping E; Niessen RC; Hogervorst FB; Gille JJ; Redeker B; Tops CM; van Gijn ME; van den Ouweland AM; Rahner N; Steinke V; Kahl P; Holinski-Feder E; Morak M; Kloor M; Stemmler S; Betz B; Hutter P; Bunyan DJ; Syngal S; Culver JO; Graham T; Chan TL; Nagtegaal ID; van Krieken JH; Schackert HK; Hoogerbrugge N; van Kessel AG; Ligtenberg MJ
Hum Mutat; 2011 Apr; 32(4):407-14. PubMed ID: 21309036
[TBL] [Abstract][Full Text] [Related]
10. Analysis of EPCAM protein expression in diagnostics of Lynch syndrome.
Kloor M; Voigt AY; Schackert HK; Schirmacher P; von Knebel Doeberitz M; Bläker H
J Clin Oncol; 2011 Jan; 29(2):223-7. PubMed ID: 21115857
[TBL] [Abstract][Full Text] [Related]
11. EPCAM germ line deletions as causes of Lynch syndrome in Spanish patients.
Guarinos C; Castillejo A; Barberá VM; Pérez-Carbonell L; Sánchez-Heras AB; Segura A; Guillén-Ponce C; Martínez-Cantó A; Castillejo MI; Egoavil CM; Jover R; Payá A; Alenda C; Soto JL
J Mol Diagn; 2010 Nov; 12(6):765-70. PubMed ID: 20864635
[TBL] [Abstract][Full Text] [Related]
12. Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome.
Niessen RC; Hofstra RM; Westers H; Ligtenberg MJ; Kooi K; Jager PO; de Groote ML; Dijkhuizen T; Olderode-Berends MJ; Hollema H; Kleibeuker JH; Sijmons RH
Genes Chromosomes Cancer; 2009 Aug; 48(8):737-44. PubMed ID: 19455606
[TBL] [Abstract][Full Text] [Related]
13. Colorectal cancer in a 9-year-old due to combined EPCAM and MSH2 germline mutations: case report of a unique genotype and immunophenotype.
Li-Chang HH; Driman DK; Levin H; Siu VM; Scanlan NL; Buckley K; Cairney AE; Ainsworth PJ
J Clin Pathol; 2013 Jul; 66(7):631-3. PubMed ID: 23454724
[No Abstract] [Full Text] [Related]
14. EPCAM germline and somatic rearrangements in Lynch syndrome: identification of a novel 3'EPCAM deletion.
Spaepen M; Neven E; Sagaert X; De Hertogh G; Beert E; Wimmer K; Matthijs G; Legius E; Brems H
Genes Chromosomes Cancer; 2013 Sep; 52(9):845-54. PubMed ID: 23801599
[TBL] [Abstract][Full Text] [Related]
15. Identification of a founder EPCAM deletion in Spanish Lynch syndrome families.
Mur P; Pineda M; Romero A; Del Valle J; Borràs E; Canal A; Navarro M; Brunet J; Rueda D; Ramón Y Cajal T; Lázaro C; Caldés T; Blanco I; Soto JL; Capellá G
Clin Genet; 2014 Mar; 85(3):260-6. PubMed ID: 23530899
[TBL] [Abstract][Full Text] [Related]
16. Frequency of deletions of EPCAM (TACSTD1) in MSH2-associated Lynch syndrome cases.
Rumilla K; Schowalter KV; Lindor NM; Thomas BC; Mensink KA; Gallinger S; Holter S; Newcomb PA; Potter JD; Jenkins MA; Hopper JL; Long TI; Weisenberger DJ; Haile RW; Casey G; Laird PW; Le Marchand L; Thibodeau SN
J Mol Diagn; 2011 Jan; 13(1):93-9. PubMed ID: 21227399
[TBL] [Abstract][Full Text] [Related]
17. EPCAM deletions, Lynch syndrome, and cancer risk.
Lynch HT; Lynch JF; Snyder CL; Riegert-Johnson D
Lancet Oncol; 2011 Jan; 12(1):5-6. PubMed ID: 21195320
[No Abstract] [Full Text] [Related]
18. New EPCAM founder deletion in Polish population.
Dymerska D; Gołębiewska K; Kuświk M; Rudnicka H; Scott RJ; Billings R; Pławski A; Boruń P; Siołek M; Kozak-Klonowska B; Szwiec M; Kilar E; Huzarski T; Byrski T; Lubiński J; Kurzawski G
Clin Genet; 2017 Dec; 92(6):649-653. PubMed ID: 28369810
[TBL] [Abstract][Full Text] [Related]
19. [A Case of Cecal Cancer Associated with Preoperatively Diagnosed Lynch Syndrome Caused by EPCAM Deletion].
Yamamoto A; Eguchi H; Suzuki O; Chika N; Ito T; Tajima Y; Kamae N; Nagai T; Takai Y; Seki H; Akagi K; Okazaki Y; Ishida H
Gan To Kagaku Ryoho; 2018 Dec; 45(13):2202-2204. PubMed ID: 30692331
[TBL] [Abstract][Full Text] [Related]
20. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ
Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]